Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

3,4-dihydroxyphenylacetic acid has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lookingland, KJ; Moore, KE; Wagner, EJ2
Akiyama, K; Kashihara, K; Kuroda, S; Sakai, K; Shohmori, T; Tsuchida, K; Ujike, H1
Cano, J; Machado, A; Merino, M; Vizuete, ML1
Cory-Slechta, DA; Reeves, R; Thiruchelvam, M1

Other Studies

5 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

ArticleYear
Non-NMDA receptor-mediated regulation of hypothalamic dopaminergic neurons in the rat.
    European journal of pharmacology, 1994, Mar-11, Volume: 254, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; alpha-MSH; Animals; Arcuate Nucleus of Hypothalamus; Dopamine; Female; Hypothalamus; Kainic Acid; Male; Median Eminence; Neostriatum; Neurons; Paraventricular Hypothalamic Nucleus; Prolactin; Quinoxalines; Rats; Receptors, Amino Acid; Receptors, AMPA; Substantia Nigra

1994
Neurochemical evidence that AMPA receptor-mediated tonic inhibition of hypothalamic dopaminergic neurons occurs via activation of inhibitory interneurons.
    Brain research, 1994, Oct-17, Volume: 660, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Hypothalamus; Interneurons; Male; Median Eminence; Neurons; Pituitary Gland; Quinoxalines; Rats; Receptors, AMPA; Receptors, Opioid, kappa

1994
AMPA receptors modulate dopamine release in the striatum, as measured by brain microdialysis.
    Neurochemistry international, 1997, Volume: 30, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Male; Microdialysis; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Tetrodotoxin

1997
The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.
    Journal of neurochemistry, 1999, Volume: 73, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Homovanillic Acid; Kynurenic Acid; Microinjections; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase

1999
Development of behavioral sensitization to the cocaine-like fungicide triadimefon is prevented by AMPA, NMDa, DA D1 but not DA D2 receptor antagonists.
    Toxicological sciences : an official journal of the Society of Toxicology, 2004, Volume: 79, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Benzazepines; Brain Chemistry; Corpus Striatum; Drug Administration Schedule; Fungicides, Industrial; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Neuronal Plasticity; Piperazines; Quinoxalines; Receptors, AMPA; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Remoxipride; Substance Withdrawal Syndrome; Time Factors; Triazoles

2004